Home  »  Markets   »  Which institution holds the most shares in RedHill...

Which institution holds the most shares in RedHill Biopharma Ltd. (RDHL)

RedHill Biopharma Ltd. (NASDAQ: RDHL) is -84.88% lower on its value in year-to-date trading and has touched a low of $0.42 and a high of $3.37 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RDHL stock was last observed hovering at around $0.43 in the last trading session, with the day’s loss setting it -0.04% off its average median price target of $1.00 for the next 12 months. It is also 61.0% off the consensus price target high of $1.00 offered by 1 analysts, but current levels are 61.0% higher than the price target low of $1.00 for the same period.

Currently trading at $0.39, the stock is -34.03% and -33.23% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.84 million and changing -8.26% at the moment leaves the stock -68.30% off its SMA200. RDHL registered -85.66% loss for a year compared to 6-month loss of -59.29%.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report

Sponsored

The stock witnessed a -37.97% gain in the last 1 month and extending the period to 3 months gives it a -62.14%, and is -19.57% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 22.09% over the week and 11.52% over the month.

RedHill Biopharma Ltd. (RDHL) has around 201 employees, a market worth around $21.29M and $83.40M in sales. Fwd P/E is 13.00. Distance from 52-week low is -7.16% and -88.43% from its 52-week high. The company has generated returns on investments over the last 12 months (-83.90%).

RedHill Biopharma Ltd. (RDHL) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for RedHill Biopharma Ltd. (RDHL) is a “Buy”. 1 analysts offering their recommendations for the stock have an average rating of 1.50, where 0 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

RedHill Biopharma Ltd. is expected to release its quarterly report on 02/23/2023.The EPS is expected to shrink by -0.50% this year

RedHill Biopharma Ltd. (RDHL) Top Institutional Holders

The shares outstanding are 52.52M, and float is at 34.99M with Short Float at 6.90%.

RedHill Biopharma Ltd. (RDHL): Who are the competitors?

The company’s main competitors (and peers) include Sanofi (SNY) that is trading -9.27% down over the past 12 months and Taro Pharmaceutical Industries Ltd. (TARO) that is -47.11% lower over the same period. Teva Pharmaceutical Industries Limited (TEVA) is 0.69% up on the 1-year trading charts.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts

Receive Best Stock To Trade Before The Opening Bell

 

 

100% Free. Stop Anytime. No Spam

111365

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.